Susan Hasty, Publisher
Table of Contents . . . July 29th, 1996Non-Subscriber - Summaries Only
Conference Coverage (Vancouver) - Canarypox HIV Vaccine: Time for Large-Scale Trials?
Conference Coverage (Vancouver) - Existing HIV Vaccines Induce Neutralizing Antibodies to Primary Isolates
Conference Coverage (Vancouver) - Genentech Researchers: Subunit Vaccine May Be Protective
AIDS Therapies (Antisense) - Antisense Compound Inhibitory Effects on Replication Steps in In Vitro Tests
AIDS Therapies (Antisense) - Immune Cell Production Reported To Be Resistant to HIV Challenges
AIDS Therapies (Antisense) - Results of Two Therapeutic Approaches Presented
DNA Vaccines (Hepatitis B) - DNA Vaccine for HBV Tested and Compared in Chimpanzee Model
Drug Development - Protein May Have Implications for Cancer Treatments
Hypertension Gene Therapy - Delivery of Therapeutic cDNA Modulates High Blood Pressure
Immunology - Stat4 Reported To Control Immune System Response
Industry News (Joint Venture) - Full-Scale Production for Intron-Free Gene Licensed
Ophthalmology - DNA-Analysis Instrumental in Identifying Infections of the Eye
Somatic Gene Therapy (Diabetes) - Hepatocytes Secrete Insulin after Therapeutic Retroviral Gene Transfer
Vaccines (Antiviral) - B7-1 Enhances CTL and Antibody Response to Hepatitis B Surface Antigen
Vector Development - Reverse Genetics Generates a Chimeric Nonsegmented Negative Strand Vector
Vector Development (Synthetic) - Stable Cationic Lipid/DNA Complexes Developed for Gene Transfer
Vectors (Anopheles gambiae) - Vertebrate Viruses Can Infect Cultured Anopheles Cells
DNA Vaccine (HIV) - "Induction of HIV-1 Nef Specific CTLs by Nef Expressing DNA Vaccine."
Drug Development (Antiviral) - "Analysis of Sequence Requirements for Biological Activity of Recombinant Cyanovirin-N, a Novel Anti-HIV Virucidal Protein."
Vector Development (HIV) - "The Use of HIV Vectors for AIDS Gene Therapy."
Antisense Technology - "Animal Models of Antisense Oligonucleotides: Lessons for Use in Humans."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.